460 related articles for article (PubMed ID: 12140666)
1. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
[TBL] [Abstract][Full Text] [Related]
2. Fasting insulin and HOMA-index changes in patients treated with valproic acid.
Mania M; Javashvili L; Kasradze S; Okujava N
Georgian Med News; 2011 Oct; (199):48-52. PubMed ID: 22155806
[TBL] [Abstract][Full Text] [Related]
3. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
Pylvänen V; Pakarinen A; Knip M; Isojärvi J
Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
[TBL] [Abstract][Full Text] [Related]
4. Obesity and endocrine disorders in women taking valproate for epilepsy.
Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV
Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
[TBL] [Abstract][Full Text] [Related]
5. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
El-Khayat HA; Abd El-Basset FZ; Tomoum HY; Tohamy SM; Zaky AA; Mohamed MS; Hakky SM; El Barbary NS; Nassef NM
Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076
[TBL] [Abstract][Full Text] [Related]
6. Valproic Acid related metabolic syndrome in patients with epilepsy.
Mania M; Kasradze S; Okujava N
Georgian Med News; 2011 May; (194):43-7. PubMed ID: 21685521
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
Kim JY; Lee HW
Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
[TBL] [Abstract][Full Text] [Related]
9. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
Isojärvi JI; Laatikainen TJ; Pakarinen AJ; Juntunen KT; Myllylä VV
N Engl J Med; 1993 Nov; 329(19):1383-8. PubMed ID: 8413434
[TBL] [Abstract][Full Text] [Related]
11. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.
Sahota P; Prabhakar S; Kharbanda PS; Bhansali A; Jain V; Das CP; Modi M
Epilepsia; 2008 Dec; 49(12):2069-77. PubMed ID: 18503558
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S
Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930
[TBL] [Abstract][Full Text] [Related]
13. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.
Luef G; Abraham I; Hoppichler F; Trinka E; Unterberger I; Bauer G; Lechleitner M
Metabolism; 2002 Oct; 51(10):1274-8. PubMed ID: 12370846
[TBL] [Abstract][Full Text] [Related]
14. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
[TBL] [Abstract][Full Text] [Related]
15. Endocrine effects of valproate in adolescent girls with epilepsy.
de Vries L; Karasik A; Landau Z; Phillip M; Kiviti S; Goldberg-Stern H
Epilepsia; 2007 Mar; 48(3):470-7. PubMed ID: 17326798
[TBL] [Abstract][Full Text] [Related]
16. Valproate-induced insulin resistance and obesity in children.
Verrotti A; la Torre R; Trotta D; Mohn A; Chiarelli F
Horm Res; 2009; 71(3):125-31. PubMed ID: 19188736
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.
Rakitin A; Kõks S; Haldre S
Seizure; 2016 May; 38():11-6. PubMed ID: 27061880
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome in women using valproate: a review.
Bilo L; Meo R
Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
[TBL] [Abstract][Full Text] [Related]
19. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
20. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
Sidhu HS; Srinivasa R; Sadhotra A
Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
